Researchers Feel Impact of Shutdown As Grant Review Stops, Funding Runs Dry
In Brief: Gift To St. Jude: $1 Million McDonald’s Ticket; Leitch Elected President, ACS Texas Division
FDA carries Action On Two Cancer Drugs Over To 1996
NRC Reports Says NIH Security Of nuclear Materials a Problem
Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?
AACR, Kellogg’s Co. Sponsor Award
Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - Imaging’s ride to the bottom in clinical trials—and why it matters now
- In The Headlines: What happens when you apply a tumor board model to financial toxicity?